RE: RE: RE: I was right!!!!!! This is it!Of course the overall market has affected RBM's slide in price. The crash took away risk money for now. But the risk money is slowly coming back in now.
The rally since March 09 is for large caps mainly, but the venture stocks and small caps are still negative. Even with this recent large cap rally, these large caps still have a long long way to go before they return to their premarket crash levels and i really doubt we will return to those lofty levels for a long time.
The market crash triggered a lot of fear and a lot of tax loss selling and small caps are usually the first to be sold- hence, RBM was a target of constant selling. So, for sure 100%, the general market conditions helped to create a bad share price.
This PP is necessary. So let's get it over with and put this delisting issue behind us.
Then, we have to wait to see if 3M can make some good sales in Flu testing. Northern hemisphere Flu season is coming to an end, but it is just starting in the Southern hemisphere. And, "Swine" flu is not going away anytime soon. It will still be with us in the fall of 2009. I expect that 3M would have deployed their sales teams to deal with the demands on a global basis.
i also expect Roche to sell ntProBNP quite successfully. i don't really expect much from Shionogi and the BNP test. They should be able to exploit this in Japan like Biosite did with its test in the ROW.
i really don't know how some can blame the CEO exlusively for the shareprice. i mean, he would have to be some kind of evil super rich genius to accomplish this feat. No, the only thing to do is watch for increasing sales, like the Q1 has proven. My intuition tells me that 2009 will open the doors to big sales and revenues. 2010 should be a breakeven year... finally.